Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone versus quetiapine for bipolar depression in adolescents and young adults
ChiCTR2100049426Phase 4Not yet recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lurasidone and quetiapine in bipolar disorder (BD) (2 arms), sponsored by Beijing Anding Hospital. Primary endpoint: Montgomery-Asberg Depression Rating Scale score. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
lurasidonequetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on ChiCTR2100049426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049426.